Biodexa Pharmaceticals Stock Probability of Future Stock Price Finishing Over 4.8
| BDRX Stock | 5.62 0.69 14.00% |
Biodexa |
Biodexa Pharmaceticals Target Price Odds to finish over 4.8
The tendency of Biodexa Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above 4.80 in 90 days |
| 5.62 | 90 days | 4.80 | about 80.96 |
Based on a normal probability distribution, the odds of Biodexa Pharmaceticals to stay above 4.80 in 90 days from now is about 80.96 (This Biodexa Pharmaceticals probability density function shows the probability of Biodexa Stock to fall within a particular range of prices over 90 days) . Probability of Biodexa Pharmaceticals price to stay between 4.80 and its current price of 5.62 at the end of the 90-day period is about 10.08 .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.26 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Biodexa Pharmaceticals will likely underperform. Additionally Biodexa Pharmaceticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Biodexa Pharmaceticals Price Density |
| Price |
Predictive Modules for Biodexa Pharmaceticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biodexa Pharmaceticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biodexa Pharmaceticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biodexa Pharmaceticals is not an exception. The market had few large corrections towards the Biodexa Pharmaceticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biodexa Pharmaceticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biodexa Pharmaceticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.22 | |
β | Beta against Dow Jones | 3.26 | |
σ | Overall volatility | 2.51 | |
Ir | Information ratio | -0.08 |
Biodexa Pharmaceticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biodexa Pharmaceticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biodexa Pharmaceticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biodexa Pharmaceticals generated a negative expected return over the last 90 days | |
| Biodexa Pharmaceticals has high historical volatility and very poor performance | |
| Biodexa Pharmaceticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 381 K. Net Loss for the year was (7.08 M) with loss before overhead, payroll, taxes, and interest of (4.41 M). | |
| Biodexa Pharmaceticals generates negative cash flow from operations | |
| Biodexa Pharmaceticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Result of General Meeting |
Biodexa Pharmaceticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biodexa Stock often depends not only on the future outlook of the current and potential Biodexa Pharmaceticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biodexa Pharmaceticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 31.6 K | |
| Cash And Short Term Investments | 6 M |
Biodexa Pharmaceticals Technical Analysis
Biodexa Pharmaceticals' future price can be derived by breaking down and analyzing its technical indicators over time. Biodexa Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biodexa Pharmaceticals. In general, you should focus on analyzing Biodexa Stock price patterns and their correlations with different microeconomic environments and drivers.
Biodexa Pharmaceticals Predictive Forecast Models
Biodexa Pharmaceticals' time-series forecasting models is one of many Biodexa Pharmaceticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biodexa Pharmaceticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Biodexa Pharmaceticals
Checking the ongoing alerts about Biodexa Pharmaceticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biodexa Pharmaceticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Biodexa Pharmaceticals generated a negative expected return over the last 90 days | |
| Biodexa Pharmaceticals has high historical volatility and very poor performance | |
| Biodexa Pharmaceticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 381 K. Net Loss for the year was (7.08 M) with loss before overhead, payroll, taxes, and interest of (4.41 M). | |
| Biodexa Pharmaceticals generates negative cash flow from operations | |
| Biodexa Pharmaceticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Result of General Meeting |
Additional Tools for Biodexa Stock Analysis
When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.